Jane Chang
Impact in
-
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
-
- Gastrointestinal Tumor Research and Treatment
Papers in ⓘ
- Co-authors
- Vivek Pawar (3 shared papers)Petros Grivas (5 shared papers)Kathleen M. Aguilar (1 shared paper)Bhakti Arondekar (1 shared paper)Christopher Ngai (5 shared papers)Jie Zhou (1 shared paper)Eric Nadler (1 shared paper)Xinke Zhang (1 shared paper)
- Journals
- Journal of Clinical Oncology (10 papers)Value in Health (9 papers)Future Oncology (7 papers)Annals of Oncology (4 papers)Clinical Genitourinary Cancer (3 papers)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
Jane Chang
46 papers receiving 214 citations
Peers
Comparison fields: 5 of 52
- Oncology 103
- Gastroenterology 19
- Pulmonary and Respiratory Medicine 75
- Reproductive Medicine 18
- Surgery 92
Countries citing papers authored by Jane Chang
This map shows the geographic impact of Jane Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jane Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jane Chang more than expected).
Fields of papers citing papers by Jane Chang
This network shows the impact of papers produced by Jane Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jane Chang. The network helps show where Jane Chang may publish in the future.
Co-authors
The 25 scholars most cited alongside Jane Chang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 50 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 32 | |
| 2 | 2020 | 31 | |
| 3 | 2016 | 15 | |
| 4 | 2014 | 13 | |
| 5 | 2009 | 13 | |
| 6 | 2014 | 9 | |
| 7 | 2020 | 8 | |
| 8 | 2023 | 8 | |
| 9 | 2023 | 8 | |
| 10 | 2021 | 5 | |
| 11 | 2020 | 5 | |
| 12 | 2023 | 5 | |
| 13 | 2018 | 5 | |
| 14 | 2024 | 4 | |
| 15 | 2023 | 4 | |
| 16 | 2017 | 3 | |
| 17 | 2025 | 3 | |
| 18 | 1999 | 3 | |
| 19 | 2015 | 3 | |
| 20 | 2023 | 3 |
About Jane Chang
Jane Chang is a scholar working on Surgery, Oncology, Pulmonary and Respiratory Medicine, Economics and Econometrics and Epidemiology, having authored 50 papers that have together received 218 indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (24 papers), Economic and Financial Impacts of Cancer (11 papers), Urinary and Genital Oncology Studies (11 papers), Health Systems, Economic Evaluations, Quality of Life (9 papers), Multiple and Secondary Primary Cancers (9 papers), Colorectal Cancer Treatments and Studies (6 papers), Ovarian cancer diagnosis and treatment (6 papers) and PARP inhibition in cancer therapy (5 papers). The work is most often cited by research in Oncology (103 citations), Gastroenterology (19 citations), Pulmonary and Respiratory Medicine (75 citations), Reproductive Medicine (18 citations) and Surgery (92 citations). Jane Chang has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Vivek Pawar, Petros Grivas, Kathleen M. Aguilar, Bhakti Arondekar, Christopher Ngai, Jie Zhou, Eric Nadler, Xinke Zhang, Evgeny Kopyltsov and Chris D. Poole. Their work appears in journals such as Journal of Clinical Oncology, Value in Health, Future Oncology, Annals of Oncology and Clinical Genitourinary Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.